跳至主要内容
临床试验/NCT00121524
NCT00121524已完成2 期

Effects of Epinephrine and I.V. Needle on CPR Outcome

Petter Andreas Steen1 个研究点 分布在 1 个国家目标入组 904 人开始时间: 2003年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
904
试验地点
1
主要终点
survival to hospital discharge with neurologic outcome

研究概览

简要总结

Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.

详细描述

In a randomized, controlled study of all out-of-hospital cardiac arrest patients in Oslo, Norway, half the patients are treated according to the international guidelines for advanced CPR, and the other half according to the same guidelines, except for no I.V. needle or drugs are given until 5 minutes after eventual return of spontaneous circulation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cardiac arrest out-of-hospital

排除标准

  • <18 years old
  • Trauma as cause of arrest

研究组 & 干预措施

IV yes

Experimental

Intravenous needle Epinephrine q 3 min during CPR Atropine 3 mg in initial asystole Amiodarone 300 mg iv after repeated failed defibrillation attempts

干预措施: Epinephrine (Drug)

IV yes

Experimental

Intravenous needle Epinephrine q 3 min during CPR Atropine 3 mg in initial asystole Amiodarone 300 mg iv after repeated failed defibrillation attempts

干预措施: Intravenous needle (Device)

IV yes

Experimental

Intravenous needle Epinephrine q 3 min during CPR Atropine 3 mg in initial asystole Amiodarone 300 mg iv after repeated failed defibrillation attempts

干预措施: Atropine (Drug)

IV yes

Experimental

Intravenous needle Epinephrine q 3 min during CPR Atropine 3 mg in initial asystole Amiodarone 300 mg iv after repeated failed defibrillation attempts

干预措施: Amiodarone (Drug)

结局指标

主要结局

survival to hospital discharge with neurologic outcome

时间窗: discharge from hospital

次要结局

  • admit to hospital with spontaneous circulation(hospital admission)
  • one year survival with neurologic outcome(one year after hospital discharge)

研究者

发起方
Petter Andreas Steen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Petter Andreas Steen

Professor Acute Medicine

University of Oslo

研究点 (1)

Loading locations...

相似试验